This research trial studies biomarkers in predicting treatment response in samples from
patients with early-stage non-small cell lung cancer previously treated with adjuvant
chemotherapy. Studying samples of tissue from patients with cancer in the laboratory may help
doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
It may also help doctors predict how patients will respond to treatment.